Citation Impact
Citing Papers
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
2006 Standout
Antidepressant effects of ketamine in depressed patients
2000 Standout
Glutamate receptor ion channels
2005 Standout
The effects of acute doses of standardized Ginkgo biloba extract on memory and psychomotor performance in volunteers
1999
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Ginkgo for Memory Enhancement
2002
Chronic Mild Stress (CMS) Revisited: Consistency and Behavioural-Neurobiological Concordance in the Effects of CMS
2005 Standout
Psychotropic Medications and Risk for Falls Among Community-Dwelling Frail Older People: An Observational Study
2005
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
2004
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)
1995
Triazolam in Alzheimer's disease: Pilot study on sleep and memory effects
1995
Erectile Dysfunction
2000 Standout
Differentiation of Glycine Antagonist Sites ofN-Methyl-d-aspartate Receptor Subtypes
1998
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis
1999
Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation
1997 Standout
Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation
2008 Standout
Hypersexual Disorder: A Proposed Diagnosis for DSM-V
2009 Standout
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Efficacy and Safety of Mizolastine in Seasonal Allergic Rhinitis
1996
Intrahippocampal spermidine administration improves inhibitory avoidance performance in rats
2000
Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain function
2011 Standout
Eliprodil, a non-competitive, NR2B-selective NMDA antagonist, protects pyramidal neurons in hippocampal slices from hypoxic/ischemic damage
1998
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Lack of subsensitivitvy to mizolastine over 8‐week treatment
1996
The Neurobiology of Sexual Function
2000
Pharmacodynamic profile of Zaleplon, a new non‐benzodiazepine hypnotic agent
2001
1,026 Experimental treatments in acute stroke
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis
1998
Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side‐effects
1999
Effects of antidepressants on cognitive functions: A review
1995
The antihistamines of the nineties
1993
Antidepressants for the new millennium
1999
Prosexual drugs: Empirical status of the ?new aphrodisiacs?
1993
NMDA receptor antagonists as analgesics: focus on the NR2B subtype
2001
The effect of Ginkgo biloba on memory in healthy male volunteers
2001
Apomorphine‐induced penile erections in Parkinson's disease
1998
Sexual Dysfunction in the United States
1999 Standout
The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers
1994
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
The Role of Actigraphy in the Study of Sleep and Circadian Rhythms
2003 Standout
Zopiclone, but not brotizolam, impairs memory storage during sleep
2003
Comorbidity of insomnia and depression
2009
Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers
1994
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin*
1998
Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects
1995
Insomnia as a predictor of depression: A meta-analytic evaluation of longitudinal epidemiological studies
2011 Standout
Recovery of erectile function by the oral administration of apomorphine
1995
Antidepressant-like effects of 1-aminocyclopropanecarboxylic acid and d-cycloserine in an animal model of depression
1996
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
2017 Standout
Zolpidem and triazolam do not affect the nocturnal sleep-induced memory improvement
2005
Meta-analysis of the Impact of 9 Medication Classes on Falls in Elderly Persons
2009 Standout
Oral Single Doses of Erythromycin and Roxithromycin May Increase the Effects of Midazolam on Human Performance
1993
Neuroprotection for ischemic stroke: Two decades of success and failure
2004
Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers
2007
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
Pharmacokinetic and Pharmacodynamic Consequences of Metabolism‐Based Drug Interactions with Alprazolam, Midazolam, and Triazolam
1999
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Pharmacology of Penile Erection
2001
The dose-dependent cognitive effects of acute administration of Ginkgo biloba to healthy young volunteers
2000
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Spermidine in health and disease
2018 StandoutScience
Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects
2001
The Glutamate Receptor Ion Channels
1999 Standout
About Sleep's Role in Memory
2013 Standout
Rapid and Sustained Efficacy of Mizolastine 10 mg Once Daily in Seasonal Allergic Rhinitis
1998
Ischemic Cell Death in Brain Neurons
1999 Standout
Lack of subsensitivity to mizolastine over 8-week treatment
1996
Biomedical Importance of Indoles
2013 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Part 14: Pediatric Advanced Life Support
2010 Standout
Study of cardiac repolarization in healthy volunteers performed with mizolastine, a new H1‐receptor antagonist
1999
Macrolide Antibacterials
1995
Place conditioning of mice with the NMDA receptor antagonists, eliprodil and dizocilpine
1998
Techniques for Analysis of Plant Phenolic Compounds
2013 Standout
Works of P. Danjou being referenced
Lack of amnestic, psychotomimetic or impairing effect on psychomotor performance of eliprodil, a new NMDA antagonist
1994
Assessment of erectogenic properties of apomorphine and yohimbine in man.
1988
COMPARATIVE EFFECTS OF ZOPICLONE, TRIAZOLAM AND PLACEBO ON MEMORY AND PSYCHOMOTOR PERFORMANCE IN HEALTHY VOLUNTEERS
1987
Effects of the selective activation of 5-HT3 receptors on sleep: a polysomnographic study in healthy volunteers
2001
Assessment of erectogenic drugs by numeric plethysmography
1989
[Effects of 3 doses of maprotiline (25, 50 and 75 mg) on alertness and memory in healthy volunteers].
1990
[Comparative effects of ginkgo biloba extracts on psychomotor performances and memory in healthy subjects].
1991
Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance
1998
A double-blind placebo controlled study of the psychometric effects of the SL 85.0324, a new H1 antagonist drag compared to terfenadhine and triprolidine in healthy subjects
1990
Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: some trait anxiety-independent responses
1992
Dose related effects of trimipramine on psychomotor function, memory, and autonomic nervous system activity in healthy volunteers
1989
CNS-pharmacodynamics and pharmacokinetics of the new non-sedative H1-antagonist SL 85.0324 vs placebo and dimetinden in volunteers
1990
Troleandomycin-triazolam interaction in healthy volunteers: Pharmacokinetic and psychometric evaluation
1987
Assessment of the anticholinergic effect of the new antihistamine mizolastine in healthy subjects.
1992